Investigating the Genetic Links Between Immune Cell Profiles and Bladder Cancer: A Multidisciplinary Bioinformatics Approach

Investigating the Genetic Links Between Immune Cell Profiles and Bladder Cancer: A Multidisciplinary Bioinformatics Approach

<b>Background</b>: Bladder cancer (BC) is a common malignancy in the urinary system, with an increasing incidence rate. Immune cell infiltration within the tumor microenvironment (TME) plays a crucial role in BC progression and treatment response. However, the immune cell composition of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jin Zhang, Zhongji Jiang, Jiali Jin, Gaohaer Kadeerhan, Hong Guo, Dongwen Wang
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Biomedicines
Subjects:	bladder cancer immune microenvironment mendelian randomization machine learning diagnostic biomarkers
Online Access:	https://www.mdpi.com/2227-9059/13/5/1203
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The genetic associations of lipidome on bladder cancer: a Mendelian randomization study
by: Jing Jin, et al.
Published: (2025-04-01)

Exploring of bladder cancer immune-related genes and potential therapeutic targets based on transcriptomic data and Mendelian randomization analysis
by: Zhangxiao Xu, et al.
Published: (2025-07-01)

Incidence, mortality, and risk factors of bladder, kidney, prostate and testicular cancers in China and comparisons with the United States, the United Kingdom, Japan, and the Republic of Korea: an up-to-date overview based on the Global Burden of Disease 2021
by: Gaohaer Kadeerhan, et al.
Published: (2025-08-01)

Circulating metabolic biomarkers mediated causal relationship between gut microbiota and bladder cancer: a two-step mendelian randomization study
by: Fa-Ye Wei, et al.
Published: (2025-05-01)

Identification of key genes as diagnostic biomarkers for IBD using bioinformatics and machine learning
by: Tianhao Li, et al.
Published: (2025-07-01)

Mendelian randomization reveals immune cell composition as a key determinant of cervical cancer prognosis
by: Yangyang Chen, et al.
Published: (2025-04-01)

Multidimensional bioinformatics perspective on smoking-linked driver genes and immune regulatory mechanisms in non-small cell lung cancer
by: Can Ouyang, et al.
Published: (2025-03-01)

Multidimensional bioinformatics analysis reveals the potential carcinogenic role of acrylamide in colorectal cancer
by: Xiaopeng Yu, et al.
Published: (2025-06-01)

CXCL12 links bladder cancer and diabetes as a potential biomarker
by: Mingyu Ma, et al.
Published: (2025-05-01)

Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
by: Hua-xiong Zhang, et al.
Published: (2025-02-01)

Unraveling the multifaceted roles of extracellular vesicles in bladder cancer: diagnostic insights and therapeutic opportunities
by: Kaiqi Huang, et al.
Published: (2025-05-01)

Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer
by: Jinlong Cao, et al.
Published: (2025-05-01)

<i>DBI</i> as a Novel Immunotherapeutic Candidate in Colorectal Cancer: Dissecting Genetic Risk and the Immune Landscape via GWAS, eQTL, and pQTL
by: Ting Tian, et al.
Published: (2025-05-01)

Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis
by: Feixiang Wu, et al.
Published: (2025-07-01)

Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
by: Anna Di Spirito, et al.
Published: (2025-03-01)

Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer
by: Haojie Dai, et al.
Published: (2025-04-01)

MSH6 as a prognostic biomarker in bladder cancer and its correlation with immunity
by: Ning He, et al.
Published: (2025-07-01)

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses
by: Pan Li, et al.
Published: (2020-10-01)

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)

From exposure to innovation: decoding aromatic amines’ role in bladder cancer mechanisms
by: Haoyu Xu, et al.
Published: (2025-05-01)

Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk
by: Wei Shen, et al.
Published: (2025-07-01)

Advances in prostate-specific membrane antigen-targeted theranostics: from radionuclides to near-infrared fluorescence technology
by: Zhongji Jiang, et al.
Published: (2025-01-01)

DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma
by: Huilin Zhang, et al.
Published: (2025-03-01)

Exploring the genetic causal inference between plasma lipidome and lung carcinoma: a bidirectional mendelian randomization study
by: Hongyu Pan, et al.
Published: (2025-05-01)

Glycosphingolipids as emerging attack points in bladder cancer
by: Inês B. Moreira, et al.
Published: (2025-04-01)

Proteomic and In Silico Analyses Highlight Complement System’s Role in Bladder Cancer Immune Regulation
by: Tuğcan Korak, et al.
Published: (2025-04-01)

Multimodal Approach to Imaging and Staging of Bladder Cancer: Diagnostic Standards and Future Trends
by: A. Sh. Kagarmanova, et al.
Published: (2024-12-01)

SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis
by: Jian Li, et al.
Published: (2025-02-01)

Immune System Alterations in the Development of Three Urological Cancers: Insights from Large-Sample Mendelian Randomization
by: Zhijian Chen, et al.
Published: (2025-06-01)

Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
by: Peng Huang, et al.
Published: (2025-01-01)

The genetic regulation of protein expression in cerebrospinal fluid
by: Oskar Hansson, et al.
Published: (2022-12-01)

Genetically predicted immune cells mediates the association between hepatocellular carcinoma and inflammatory proteins: a Mendelian randomization study
by: Yunlan Wang, et al.
Published: (2025-06-01)

Genetic Causality of Hypothyroidism and Adverse Pregnancy Outcomes: A Combined Mendelian Randomisation Study and Bioinformatics Analysis
by: Feng Z, et al.
Published: (2024-12-01)

An essential role for decorin in bladder cancer invasiveness
by: Mohamed El Behi, et al.
Published: (2013-10-01)

Mendelian randomization and genetic analyses reveal causal roles of immune cells and inflammatory proteins in keratoconus
by: Jialin Chen, et al.
Published: (2025-07-01)

Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)

Genetically Predicted Serum 25‐Hydroxyvitamin D Concentrations in Related to Type 2 Diabetes Mellitus: A Mendelian Randomization Study
by: Jin Yang
Published: (2025-07-01)

Bidirectional two-sample Mendelian randomization reveals causal link between genetic blood metabolites and tuberculosis
by: Zhenyu Shi, et al.
Published: (2025-06-01)

Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
by: Fuyang Liu, et al.
Published: (2025-05-01)

The interplay between angiogenesis-associated genes and molecular, clinical, and immune features in bladder cancer
by: Xiaoxiao Guo, et al.
Published: (2025-03-01)